Detalhe da pesquisa
1.
A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcoma.
Cancer
; 127(6): 894-904, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33231866
2.
Sorafenib for Advanced and Refractory Desmoid Tumors.
N Engl J Med
; 379(25): 2417-2428, 2018 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30575484
3.
Patterns of response with talimogene laherparepvec in combination with ipilimumab or ipilimumab alone in metastatic unresectable melanoma.
Br J Cancer
; 121(5): 417-420, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31353364
4.
Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials.
Lancet Oncol
; 19(3): 416-426, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29370992
5.
Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy.
BMC Cancer
; 18(1): 413, 2018 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29649990
6.
Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy.
BMC Cancer
; 18(1): 225, 2018 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29486723
7.
Improved survival for extremity soft tissue sarcoma treated in high-volume facilities.
J Surg Oncol
; 117(7): 1479-1486, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29633281
8.
Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma.
Cancer
; 123(23): 4640-4647, 2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28832986
9.
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor.
Cancer
; 123(1): 90-97, 2017 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27696380
10.
Epigenetic silencing of the human NOS2 gene: rethinking the role of nitric oxide in human macrophage inflammatory responses.
J Immunol
; 192(5): 2326-38, 2014 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24477906
11.
Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial.
JAMA
; 311(23): 2397-405, 2014 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-24938562
12.
Postoperative Echography for Optimization of Radiation Dosimetry in Patients with Uveal Melanoma Treated with Plaque Brachytherapy.
Ophthalmol Retina
; 7(7): 620-627, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36822323
13.
T2* Imaging Assessment of Neoadjuvant Radiation Therapy Combined With Pharmacological Ascorbate in Extremity Soft-Tissue Sarcomas: A Pilot Study.
Iowa Orthop J
; 43(2): 60-69, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38213860
14.
SALVO: Single-Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma.
Clin Cancer Res
; 29(12): 2220-2225, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37000165
15.
Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II trial.
J Immunother Cancer
; 11(5)2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142291
16.
The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma.
J Clin Med
; 12(7)2023 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37048645
17.
Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial.
Neuro Oncol
; 25(1): 146-156, 2023 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35639513
18.
Surgical management for giant bladder leiomyosarcoma.
Urol Case Rep
; 42: 101995, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35059300
19.
Detection of Ferritin Expression in Soft Tissue Sarcomas With MRI: Potential Implications for Iron Metabolic Therapy.
Iowa Orthop J
; 42(1): 255-262, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35821920
20.
The Impact of TSC-1 and -2 Mutations on Response to Therapy in Malignant PEComa: A Multicenter Retrospective Analysis.
Genes (Basel)
; 13(11)2022 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36360169